Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

NeoRx's Pretarget technology permits higher doses of radiation in lymphoma patients

June 16, 1999

Dendritic cell therapy: a novel treatment strategy for breast and ovarian cancers

June 15, 1999

Phase I results on adenoviral-p53 therapy in non-small cell lung cancer

June 15, 1999

Mechanism underlying Oxigene's tumor vascular targeting agent revealed

June 15, 1999

Protein kinase inhibitors especially useful for cancer in development at BMS

June 14, 1999

Medarex identifies valid Bispecific antibody approach to lymphoma Rx

June 14, 1999

First results of phase I/II trial evaluating arsenic trioxide in CML presented in Barcelona

June 14, 1999

Major licensing agreement announced for former IDEC-Y2B8

June 11, 1999

Bcr-Abl kinase inhibitor CGP-57148B featured at hematology meeting

June 11, 1999

Spongistatin-like cytotoxic agents developed at U. of Pennsylvania

June 11, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
Unmasking the X: EPAC2 shifts the fragile X landscape
BioWorld
Researchers at UCLA have shown that divergent neuronal signaling in fragile X mice converges on EPAC2, a druggable target whose inhibition restores circuit...
Recludix presents STAT1/3 inhibitors for dermatological diseases
BioWorld Science
Recludix Pharma Inc. recently presented data on their new STAT1/3 inhibitors REX-6553 and REX-6547 for treating dermatological inflammatory skin diseases.